250 related articles for article (PubMed ID: 23857711)
1. The role of impedance monitoring in patients with extraesophageal symptoms.
Kavitt RT; Yuksel ES; Slaughter JC; Garrett CG; Hagaman D; Higginbotham T; Vaezi MF
Laryngoscope; 2013 Oct; 123(10):2463-8. PubMed ID: 23857711
[TBL] [Abstract][Full Text] [Related]
2. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
[TBL] [Abstract][Full Text] [Related]
4. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
Blonski W; Vela MF; Castell DO
J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
[TBL] [Abstract][Full Text] [Related]
5. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
[TBL] [Abstract][Full Text] [Related]
7. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
Vailati C; Mazzoleni G; Testoni PA; Passaretti S
J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
[TBL] [Abstract][Full Text] [Related]
8. Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.
Patel DA; Sharda R; Choksi YA; Slaughter JC; Higginbotham T; Garrett CG; Francis DO; Ravi K; Hasak S; Katzka D; Gyawali CP; Vaezi MF
Gastroenterology; 2018 Dec; 155(6):1729-1740.e1. PubMed ID: 30170117
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
10. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
11. Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry.
Shi Y; Tan N; Zhang N; Xiong L; Peng S; Lin J; Chen M; Xiao Y
Neurogastroenterol Motil; 2016 May; 28(5):674-9. PubMed ID: 26768192
[TBL] [Abstract][Full Text] [Related]
12. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
13. Utilization of wireless pH monitoring technologies: a summary of the proceedings from the esophageal diagnostic working group.
Richter JE; Pandolfino JE; Vela MF; Kahrilas PJ; Lacy BE; Ganz R; Dengler W; Oelschlager BK; Peters J; DeVault KR; Fass R; Gyawali CP; Conklin J; DeMeester T;
Dis Esophagus; 2013; 26(8):755-65. PubMed ID: 22882487
[TBL] [Abstract][Full Text] [Related]
14. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
15. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
[TBL] [Abstract][Full Text] [Related]
16. Most Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Also Have Functional Esophageal Disorders.
Abdallah J; George N; Yamasaki T; Ganocy S; Fass R
Clin Gastroenterol Hepatol; 2019 May; 17(6):1073-1080.e1. PubMed ID: 29913281
[TBL] [Abstract][Full Text] [Related]
17. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
18. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
[TBL] [Abstract][Full Text] [Related]
19. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
Lacy BE; Chehade R; Crowell MD
Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
[TBL] [Abstract][Full Text] [Related]
20. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
Frazzoni M; Conigliaro R; Mirante VG; Melotti G
Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]